A potential development in mouth cancer treatment has been discovered by researchers from the Albert Einstein College of Medicine of Yeshiva University, New York, USA.

Research has suggested an anti-cancer compound could help treat mouth cancer, and studies showed that the compound killed mouth cancer cells removed from head and neck cancer patients.

Currently just half of those diagnosed with mouth cancer survive beyond five years. Nearly 5,000 are diagnosed in the UK each year. In the study, scientists tested a drug for its effects on blood cancer.